| __timestamp | Opthea Limited | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2652041 | 6795238 |
| Thursday, January 1, 2015 | 2361587 | 7454247 |
| Friday, January 1, 2016 | 4472869 | 10345862 |
| Sunday, January 1, 2017 | 5030957 | 16984203 |
| Monday, January 1, 2018 | 4988941 | 16187290 |
| Tuesday, January 1, 2019 | 5196412 | 9299233.54 |
| Wednesday, January 1, 2020 | 6652774 | 19232000 |
| Friday, January 1, 2021 | 18418247 | 23611000 |
| Saturday, January 1, 2022 | 24827066 | 26700000 |
| Sunday, January 1, 2023 | 41896408 | 28215000 |
| Monday, January 1, 2024 | 15488619 |
Infusing magic into the data realm
In the competitive world of biotechnology, operational efficiency is key. This analysis of Selling, General, and Administrative (SG&A) expenses from 2014 to 2023 highlights the financial strategies of Summit Therapeutics Inc. and Opthea Limited. Over the past decade, Summit Therapeutics has consistently outpaced Opthea in SG&A spending, peaking in 2023 with expenses reaching approximately 28 million USD. Opthea, however, has shown a remarkable increase, with a 58% rise in SG&A expenses from 2022 to 2023, reaching around 42 million USD. This surge suggests a strategic pivot, possibly towards aggressive market expansion or increased R&D investments. Interestingly, data for Summit in 2024 is missing, leaving room for speculation on their future financial maneuvers. As these companies navigate the biotech landscape, their SG&A trends offer a window into their operational priorities and market strategies.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Summit Therapeutics Inc.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Summit Therapeutics Inc.
Neurocrine Biosciences, Inc. and Opthea Limited: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Viatris Inc. vs Summit Therapeutics Inc. Trends and Insights
Summit Therapeutics Inc. vs Blueprint Medicines Corporation: SG&A Expense Trends
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Rhythm Pharmaceuticals, Inc.
Summit Therapeutics Inc. vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Alkermes plc vs Opthea Limited
Who Optimizes SG&A Costs Better? Opthea Limited or Perrigo Company plc
Opthea Limited and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Opthea Limited and BioCryst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and MiMedx Group, Inc.